Solesence, Inc. Common Stock
NASDAQ:SLSNHousehold & Personal Products
+$0.05 today
- Market cap
- $115.86M
- Beta
- 1.24
- P/E (TTM)
- 99.5
- EPS (TTM)
- $0.01
Volume 0.30M
Average 0.04M
SLSN Net Income
Bottom-line profit after all expenses, interest, and taxes.
Solesence, Inc. Common StockNASDAQ: SLSN
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income turns negative
Q1 FY2026 net income was -$766K, compared with $80K a year earlier. Trailing-twelve-month net income was $944K.
Context
- Net income amounted to 2.9% of revenue in FY2025, down 5.2 pp from a year earlier.
- Net income increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly net income holds near -$766K or moves back toward the trailing-twelve-month quarterly average of $236K.
Sources:Income StatementText generated from reported figures; not investment advice.
Net Income history
USD · from the income statement
- Latest · FY2025
- 1.79M USD
- Year-over-year change
- -57.7%
- 4-year CAGR
- -6.3%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.79M | -57.7% |
| FY2024 | 2024-12-31 | 4.24M | +196.5% |
| FY2023 | 2023-12-31 | (4.39M) | -67.4% |
| FY2022 | 2022-12-31 | (2.62M) | -213.1% |
| FY2021 | 2021-12-31 | 2.32M | — |
Net Income vs competitors
How SLSN compares with its peers on the latest reported figures
- SLSN's LTM Mar 2026 net income of $944K is the 4th highest of the 8 companies compared; the peer median is -$6.02M.
- Its year-over-year change of -72.4% is the 6th highest of 7, against a peer median of +39.6%.
- Net income amounts to 1.6% of revenue for SLSN, versus a peer median of 5.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $19.89M | +96.5% | — | 4.1% | |
| LTM Mar 2026 | $9.52M | -5.2% | +49.7% | 4.7% | |
| LTM Mar 2026 | $6.03M | -31.8% | +12.6% | 6.6% | |
SLSNSolesence, Inc. Common Stock | LTM Mar 2026 | $944K | -72.4% | — | 1.6% |
| LTM Mar 2026 | -$6.02M | +84.4% | — | 2.0% | |
AFRIForafric Global PLC | LTM Jun 2024 | -$16.81M | — | — | 5.2% |
| LTM Mar 2026 | -$18.98M | +86.5% | — | 115.6% | |
| LTM Apr 2026 | -$40.39M | -2274.7% | — | 30.5% | |
| Peer median (excluding SLSN) | -$6.02M | +39.6% | +31.2% | 5.2% | |
Competitors are the stored peer set for SLSN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 29.48M | 37.32M | 37.3M | 52.35M | 62.06M |
| Cost of Revenue | 20.79M | 28.96M | 29.47M | 36.16M | 46.04M |
| Gross Profit | 8.69M | 8.36M | 7.83M | 16.19M | 16.03M |
| Gross Margin | 29.5% | 22.4% | 21.0% | 30.9% | 25.8% |
| Research & Development | 2.24M | 3.04M | 3.84M | 3.84M | 4.08M |
| Selling, General & Admin | 3.9M | 7.58M | 7.53M | 7.22M | 10.38M |
| Operating Expenses | 6.13M | 10.62M | 11.37M | 11.06M | 14.46M |
| Depreciation & Amortization | 454K | 567K | 742K | 928K | 897K |
| EBITDA | 3.97M | (1.69M) | (2.8M) | 6.06M | 3.69M |
| EBITDA Margin | 13.5% | -4.5% | -7.5% | 11.6% | 5.9% |
| Operating Income | 2.56M | (2.26M) | (3.55M) | 5.13M | 1.57M |
| Operating Margin | 8.7% | -6.1% | -9.5% | 9.8% | 2.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.15M | 382K | 838K | 670K | 931K |
| Other Income / Expenses | (202K) | (382K) | (838K) | (670K) | 291K |
| Income Before Tax | 2.36M | (2.64M) | (4.38M) | 4.46M | 1.86M |
| Pre-Tax Margin | 8.0% | -7.1% | -11.8% | 8.5% | 3.0% |
| Income Tax Expense | 37K | (17K) | 6K | 227K | 73K |
| Net Income | 2.32M | (2.62M) | (4.39M) | 4.24M | 1.79M |
| Net Margin | 7.9% | -7.0% | -11.8% | 8.1% | 2.9% |
| EPS (Basic) | 0.05 | (0.05) | (0.09) | 0.07 | 0.03 |
| EPS (Diluted) | 0.05 | (0.05) | (0.09) | 0.07 | 0.02 |
| Weighted Avg Shares | 45.02M | 49.12M | 49.56M | 62.35M | 70.34M |
| Weighted Avg Shares (Diluted) | 47.04M | 49.12M | 49.56M | 65.03M | 72.58M |
Solesence, Inc. Common Stock
NASDAQ:SLSN
Intrinsic Alpha fair value
Locked
Current Price
$1.64
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.